Hormonal treatments for adenomyosis

Ferenczy, 1998, Pathophysiology of adenomyosis, Hum Reprod Update, 4, 312, 10.1093/humupd/4.4.312 Bergeron, 2006, Pathology and physiopathology of adenomyosis, Best Pract Res Clin Obstet Gynaecol, 20, 511, 10.1016/j.bpobgyn.2006.01.016 Vercellini, 2006, Adenomyosis: epidemiological factors, Best Pract Res Clin Obstet Gynaecol, 20, 465, 10.1016/j.bpobgyn.2006.01.017 Matalliotakis, 2003, Adenomyosis, Obstet Gynecol Clin North Am, 30, 63, 10.1016/S0889-8545(02)00053-0 Sanberg, 1962, Adenomyosis in the gravid uterus at term, Am J Obstet Gynecol, 84, 1457, 10.1016/S0002-9378(16)35790-8 Zaloudek, 1987, Mesenchymal tumors of the uterus, 374 Hendrickson, 1987, Non-neoplastic conditions of the myometrium and uterine serosa, 405 Levgur, 2000, Adenomyosis: symptoms, histology, and pregnancy terminations, Obstet Gynecol, 95, 688, 10.1016/S0029-7844(99)00659-6 Sammour, 2002, Correlations between extent and spread of adenomyosis and clinical symptoms, Gynecol Obstet Invest, 54, 213, 10.1159/000068385 Kunz, 2000, Structural abnormalities of the uterine wall in women with endometriosis and infertility visualized by vaginal sonography and magnetic resonance imaging, Hum Reprod, 15, 76, 10.1093/humrep/15.1.76 Kunz, 2005, Adenomyosis in endometriosis: prevalence and impact on fertility. Evidence from magnetic resonance imaging, Hum Reprod, 20, 2309, 10.1093/humrep/dei021 Fedele, 1992, Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis, Fertil Steril, 58, 94, 10.1016/S0015-0282(16)55142-5 Uduwela, 2000, Endometrial–myometrial interface: relationship to adenomyosis and changes in pregnancy, Obstet Gynecol Surv, 55, 390, 10.1097/00006254-200006000-00025 Arnold, 1995, The nonsurgical diagnosis of adenomyosis, Obstet Gynecol, 86, 461, 10.1016/0029-7844(95)00193-U Ascher, 2003, Benign myometrial conditions: leiomyomas and adenomyosis, Top Magn Reson Imaging, 14, 281, 10.1097/00002142-200308000-00003 Brosens, 1995, Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics, Br J Obstet Gynaecol, 102, 471, 10.1111/j.1471-0528.1995.tb11320.x Rabinovici, 2006, New interventional techniques for adenomyosis, Best Pract Res Clin Obstet Gynaecol, 20, 617, 10.1016/j.bpobgyn.2006.02.002 Tamaya, 1979, Steroid receptor levels and histology of endometriosis and adenomyosis, Fertil Steril, 31, 396, 10.1016/S0015-0282(16)43935-X Ueki, 2004, Expression of apoptosis-related proteins in adenomyotic uteri treated with danazol and GnRH agonists, Int J Gynecol Pathol, 23, 248, 10.1097/01.pgp.0000130109.80359.57 Urabe, 1989, Estrogen biosynthesis in human uterine adenomyosis, Acta Endocrinol (Copenh), 121, 259, 10.1530/acta.0.1210259 Yamamoto, 1993, Evidence for estrogen synthesis in adenomyotic tissues, Am J Obstet Gynecol, 169, 734, 10.1016/0002-9378(93)90654-2 Ezaki, 2001, Immunohistologic localization of estrone sulfatase in uterine endometrium and adenomyosis, Obstet Gynecol, 98, 815, 10.1016/S0029-7844(01)01554-X Otsuki, 1994, Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle, Lancet, 344, 28, 10.1016/S0140-6736(94)91051-0 Grow, 1991, Treatment of adenomyosis with long-term GnRH analogues: a case report, Obstet Gynecol, 78, 538 Nelson, 1993, Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report, Fertil Steril, 59, 441, 10.1016/S0015-0282(16)55704-5 Huang, 1999, Effects of short-course buserelin therapy on adenomyosis. A report of two cases, J Reprod Med, 44, 741 Hirata, 1993, Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist, Fertil Steril, 59, 444, 10.1016/S0015-0282(16)55703-3 Silva, 1994, Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist, Fertil Steril, 61, 171, 10.1016/S0015-0282(16)56471-1 Lin, 2000, Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility, Chin Med J (Engl), 113, 442 Huang, 1998, Successful pregnancy after treatment of deep adenomyosis with cytoreductive surgery and subsequent gonadotropin-releasing hormone agonist: a case report, Chin Med J (Engl), 61, 726 Edelman, 2005, Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception, Cochrane Database Syst Rev, 20, CD004695 Critchley, 1998, Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery, Hum Reprod, 13, 1218, 10.1093/humrep/13.5.1218 Varma, 2006, Non-contraceptive uses of levonorgestrel-releasing hormone system (Lng-IUS). A systematic enquiry and overview, Eur J Obstet Gynecol Reprod Biol, 125, 9, 10.1016/j.ejogrb.2005.10.029 Fedele, 1997, Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device, Fertil Steril, 68, 426, 10.1016/S0015-0282(97)00245-8 Fong, 1999, Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system, Contraception, 60, 173, 10.1016/S0010-7824(99)00075-X He, 2005, Effect of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis, Zhonghua Fu Chan Ke Za Zhi, 40, 536 Maia, 2003, Insertion of Mirena after endometrial resection in patients with adenomyosis, J Am Assoc Gynecol Laparosc, 10, 512, 10.1016/S1074-3804(05)60158-2 Igarashi, 2000, Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device, Fertil Steril, 74, 412, 10.1016/S0015-0282(00)00624-5 Farquhar, 2006, Medical and surgical management of adenomyosis, Best Pract Res Clin Obstet Gynaecol, 20, 603, 10.1016/j.bpobgyn.2006.01.012